|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thomas A, Khan SA, Chrischilles EA and
Schroeder MC: Initial surgery and survival in stage IV breast
cancer in the United States, 1988–2011. JAMA Surg. 151:424–431.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xiong Z, Deng G, Wang J, Li X, Xie X,
Shuang Z and Wang X: Could local surgery improve survival in de
novo stage IV breast cancer? BMC Cancer. 18:8852018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Eng LG, Dawood S, Sopik V, Haaland B, Tan
PS, Bhoo-Pathy N, Warner E, Iqbal J, Narod SA and Dent R: Ten-year
survival in women with primary stage IV breast cancer. Breast
Cancer Res Treat. 160:145–152. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Malmgren JA, Mayer M, Atwood MK and Kaplan
HG: Differential presentation and survival of de novo and recurrent
metastatic breast cancer over time: 1990–2010. Breast Cancer Res
Treat. 167:579–590. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tao L, Chu L, Wang LI, Moy L, Brammer M,
Song C, Green M, Kurian AW, Gomez SL and Clarke CA: Occurrence and
outcome of de novo metastatic breast cancer by subtype in a large,
diverse population. Cancer Causes Control. 27:1127–1138. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yoo TK, Chae BJ, Kim SJ, Lee J, Yoon TI,
Lee SJ, Park HY, Park HK, Eom YH, Kim HS, et al: Identifying
long-term survivors among metastatic breast cancer patients
undergoing primary tumor surgery. Breast Cancer Res Treat.
165:109–118. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lane WO, Thomas SM, Blitzblau RC, Plichta
JK, Rosenberger LH, Fayanju OM, Hyslop T, Hwang ES and Greenup RA:
Surgical resection of the primary tumor in women with de novo stage
IV breast cancer: Contemporary practice patterns and survival
analysis. Ann Surg. 269:537–544. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bafford AC, Burstein HJ, Barkley CR, Smith
BL, Lipsitz S, Iglehart JD, Winer EP and Golshan M: Breast surgery
in stage IV breast cancer: Impact of staging and patient selection
on overall survival. Breast Cancer Res Treat. 115:7–12. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rapiti E, Verkooijen HM, Vlastos G,
Fioretta G, Neyroud-Caspar I, Sappino AP, Chappuis PO and Bouchardy
C: Complete excision of primary breast tumor improves survival of
patients with metastatic breast cancer at diagnosis. J Clin Oncol.
24:2743–2749. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Babiera GV, Rao R, Feng L, Meric-Bernstam
F, Kuerer HM, Singletary SE, Hunt KK, Ross MI, Gwyn KM, Feig BW, et
al: Effect of primary tumor extirpation in breast cancer patients
who present with stage IV disease and an intact primary tumor. Ann
Surg Oncol. 13:776–782. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gnerlich J, Jeffe DB, Deshpande AD, Beers
C, Zander C and Margenthaler JA: Surgical removal of the primary
tumor increases overall survival in patients with metastatic breast
cancer: Analysis of the 1988–2003 SEER data. Ann Surg Oncol.
14:2187–2194. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fields RC, Jeffe DB, Trinkaus K, Zhang Q,
Arthur C, Aft R, Dietz JR, Eberlein TJ, Gillanders WE and
Margenthaler JA: Surgical resection of the primary tumor is
associated with increased long-term survival in patients with stage
IV breast cancer after controlling for site of metastasis. Ann Surg
Oncol. 14:3345–3351. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bhoo-Pathy N, Verkooijen HM, Tan EY, Miao
H, Taib NA, Brand JS, Dent RA, See MH, Subramaniam S, Chan P, et
al: Trends in presentation, management and survival of patients
with de novo metastatic breast cancer in a Southeast Asian setting.
Sci Rep. 5:162522015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pons-Tostivint E, Alouani E, Kirova Y,
Dalenc F and Vaysse C: Is there a role for locoregional treatment
of the primary tumor in de novo metastatic breast cancer in the era
of tailored therapies?: Evidences, unresolved questions and a
practical algorithm. Crit Rev Oncol Hematol. 157:1031462021.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pons-Tostivint E, Kirova Y, Lusque A,
Campone M, Geffrelot J, Mazouni C, Mailliez A, Pasquier D,
Madranges N, Firmin N, et al: Survival impact of locoregional
treatment of the primary tumor in de novo metastatic breast cancers
in a large multicentric cohort study: A propensity score-matched
analysis. Ann Surg Oncol. 26:356–365. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Soran A, Ozmen V, Ozbas S, Karanlik H,
Muslumanoglu M, Igci A, Canturk Z, Utkan Z, Ozaslan C, Evrensel T,
et al: Randomized trial comparing resection of primary tumor with
no surgery in stage IV breast cancer at presentation: Protocol
MF07-01. Ann Surg Oncol. 25:3141–3149. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fitzal F, Bjelic-Radisic V, Knauer M,
Steger G, Hubalek M, Balic M, Singer C, Bartsch R, Schrenk P,
Soelkner L, et al: Impact of breast surgery in primary metastasized
breast cancer: Outcomes of the prospective randomized phase III
ABCSG-28 POSYTIVE trial. Ann Surg. 269:1163–1169. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Badwe R, Hawaldar R, Nair N, Kaushik R,
Parmar V, Siddique S, Budrukkar A, Mittra I and Gupta S:
Locoregional treatment versus no treatment of the primary tumour in
metastatic breast cancer: An open-label randomised controlled
trial. Lancet Oncol. 16:1380–1388. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Harris E, Barry M and Kell MR:
Meta-analysis to determine if surgical resection of the primary
tumour in the setting of stage IV breast cancer impacts on
survival. Ann Surg Oncol. 20:2828–2834. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Petrelli F and Barni S: Surgery of primary
tumors in stage IV breast cancer: An updated meta-analysis of
published studies with meta-regression. Med Oncol. 29:3282–3290.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xiao W, Zou Y, Zheng S, Hu X, Liu P and
Xie X, Yu P, Tang H and Xie X: Primary tumor resection in stage IV
breast cancer: A systematic review and meta-analysis. Eur J Surg
Oncol. 44:1504–1512. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Headon H, Wazir U, Kasem A and Mokbel K:
Surgical treatment of the primary tumour improves the overall
survival in patients with metastatic breast cancer: A systematic
review and meta-analysis. Mol Clin Oncol. 4:863–867. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gera R, Chehade HELH, Wazir U, Tayeh S,
Kasem A and Mokbel K: Locoregional therapy of the primary tumour in
de novo stage IV breast cancer in 216 066 patients: A
meta-analysis. Sci Rep. 10:29522020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Arciero C, Liu Y, Gillespie T and Subhedar
P: Surgery and survival in patients with stage IV breast cancer.
Breast J. 25:644–653. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cortesi L, Toss A, Cirilli C, Marcheselli
L, Braghiroli B, Sebastiani F and Federico M: Twenty-years
experience with de novo metastatic breast cancer. Int J Cancer.
137:1417–1426. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao W, Wu L, Zhao A, Zhang M, Tian Q,
Shen Y, Wang F, Wang B, Wang L, Chen L, et al: A nomogram for
predicting survival in patients with de novo metastatic breast
cancer: A population-based study. BMC Cancer. 20:9822020.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Di Meglio A, Freedman RA, Lin NU, Barry
WT, Metzger-Filho O, Keating NL, King TA, Sertoli MR, Boccardo F,
Winer EP and Vaz-Luis I: Time trends in incidence rates and
survival of newly diagnosed stage IV breast cancer by tumor
histology: A population-based analysis. Breast Cancer Res Treat.
157:587–596. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bitencourt A, Rossi Saccarelli C, Morris
EA, Flynn J, Zhang Z, Khan A, Gillespie E, Cahlon O, Mueller B,
Cuaron JJ, et al: Regional lymph node involvement among patients
with de novo metastatic breast cancer. JAMA Netw Open.
3:e20187902020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shen T, Siegal GP and Wei S:
Clinicopathologic factors associated with de novo metastatic breast
cancer. Pathol Res Pract. 212:1167–1173. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shen T, Gao C, Zhang K, Siegal GP and Wei
S: Prognostic outcomes in advanced breast cancer: The
metastasis-free interval is important. Hum Pathol. 70:70–76. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lobbezoo DJA, van Kampen RJW, Voogd AC,
Dercksen MW, van den Berkmortel F, Smilde TJ, van de Wouw AJ,
Peters FP, van Riel JMGH, Peters NAJB, et al: Prognosis of
metastatic breast cancer: Are there differences between patients
with de novo and recurrent metastatic breast cancer? Br J Cancer.
112:1445–1251. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dawood S, Broglio K, Ensor J, Hortobagyi
GN and Giordano SH: Survival differences among women with de novo
stage IV and relapsed breast cancer. Ann Oncol. 21:2169–2174. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yardley DA, Kaufman PA, Brufsky A, Yood
MU, Rugo H, Mayer M, Quah C, Yoo B and Tripathy D: Treatment
patterns and clinical outcomes for patients with de novo versus
recurrent HER2-positive metastatic breast cancer. Breast Cancer Res
Treat. 145:725–734. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lao C, Kuper-Hommel M, Elwood M, Campbell
I, Edwards M and Lawrenson R: Characteristics and survival of de
novo and recurrent metastatic breast cancer in New Zealand. Breast
Cancer. 28:387–397. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
den Brok WD, Speers CH, Gondara L, Baxter
E, Tyldesley SK and Lohrisch CA: Survival with metastatic breast
cancer based on initial presentation, de novo versus relapsed.
Breast Cancer Res Treat. 161:549–556. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nieder C, Mannsåker B and Haukland E:
Exceptional responses to standard therapy in a patient with
metastatic HER2-positive breast cancer. Cureus.
9:e14122017.PubMed/NCBI
|
|
38
|
Gobbini E, Ezzalfani M, Dieras V, Bachelot
T, Brain E, Debled M, Jacot W, Mouret-Reynier MA, Goncalves A,
Dalenc F, et al: Time trends of overall survival among metastatic
breast cancer patients in the real-life ESME cohort. Eur J Cancer.
96:17–24. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Elbaiomy MA, Akl T, Atwan N, Elsayed AA,
Elzaafarany M and Shamaa S: Clinical impact of breast cancer stem
cells in metastatic breast cancer patients. J Oncol.
2020:25617262020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dawood S, Haaland B, Albaracin C, Gupta S,
Cortes J, Sim YY and Dent RA: Is the proportion of patients
diagnosed with synchronous stage IV breast cancer who survive more
than two years increasing over time? Oncology. 89:79–87. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ogiya R, Sagara Y, Niikura N and Freedman
RA: Impact of subtype on survival of young patients with stage IV
breast cancer. Clin Breast Cancer. 19:200–207.e1. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Vaz-Luis I, Lin NU, Keating NL, Barry WT,
Winer EP and Freedman RA: Factors associated with early mortality
among patients with de novo metastatic breast cancer: A
population-based study. Oncologist. 22:386–393. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen H, Zhang M, Wang M, Zhang P, Bai F
and Wu K: Immediate breast reconstruction in de novo metastatic
breast cancer: An analysis of 563 cases based on the SEER database.
Clin Breast Cancer. 19:e135–e141. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Khan SA, Stewart AK and Morrow M: Does
aggressive local therapy improve survival in metastatic breast
cancer? Surgery. 132:620–627. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Soares LR, Freitas-Junior R, Curado MP,
Paulinelli RR, Martins E and Oliveira JC: Low overall survival in
women with de novo metastatic breast cancer: Does this reflect
tumor biology or a lack of access to health care? JCO Glob Oncol.
6:679–687. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Blanchard DK, Shetty PB, Hilsenbeck SG and
Elledge RM: Association of surgery with improved survival in stage
IV breast cancer patients. Ann Surg. 247:732–738. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
King TA, Lyman JP, Gonen M, Voci A, De
Brot M, Boafo C, Sing AP, Hwang ES, Alvarado MD, Liu MC, et al:
Prognostic impact of 21-gene recurrence score in patients with
stage IV breast cancer: TBCRC 013. J Clin Oncol. 34:2359–2365.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Carmichael AR, Anderson EDC, Chetty U and
Dixon JM: Does local surgery have a role in the management of stage
IV breast cancer? Eur J Surg Oncol. 29:17–19. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lin C, Wu J, Ding S, Goh C, Andriani L, Lu
S, Shen K and Zhu L: Subdivision of M1 stage for de novo metastatic
breast cancer to better predict prognosis and response to primary
tumor surgery. J Natl Compr Canc Netw. 17:1521–1528. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Plichta JK, Thomas SM, Sergesketter AR,
Greenup RA, Rosenberger LH, Fayanju OM, Kimmick G, Force J, Hyslop
T and Hwang ES: A novel staging system for de novo metastatic
breast cancer refines prognostic estimates. Ann Surg. 275:784–792.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Garrido-Castro AC, Spurr LF, Hughes ME, Li
YY, Cherniack AD, Kumari P, Lloyd MR, Bychkovsky B, Barroso-Sousa
R, Di Lascio S, et al: Genomic characterization of de novo
metastatic breast cancer. Clin Cancer Res. 27:1105–1118. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Seltzer S, Corrigan M and O'Reilly S: The
clinicomolecular landscape of de novo versus relapsed stage IV
metastatic breast cancer. Exp Mol Pathol. 114:1044042020.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
McKenzie HS, Maishman T, Simmonds P,
Durcan L; POSH Steering Group, ; Eccles D and Copson E: Survival
and disease characteristics of de novo versus recurrent metastatic
breast cancer in a cohort of young patients. Br J Cancer.
122:1618–1629. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Di Meglio A, Lin NU, Freedman RA, Barry
WT, Winer EP and Vaz-Luis I: Patterns of utilization of imaging
studies and serum tumor markers among patients with de novo
metastatic breast cancer. J Natl Compr Canc Netw. 15:316–324. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Shien T, Kinoshita T, Shimizu C, Hojo T,
Taira N, Doihara H and Akashi-Tanaka S: Primary tumor resection
improves the survival of younger patients with metastatic breast
cancer. Oncol Rep. 21:827–832. 2009.PubMed/NCBI
|
|
56
|
Barinoff J, Schmidt M, Schneeweiss A,
Schoenegg W, Thill M, Keitel S, Lattrich CR, Hinke A, Kutscheidt A
and Jackisch C: Primary metastatic breast cancer in the era of
targeted therapy-prognostic impact and the role of breast tumour
surgery. Eur J Cancer. 83:116–124. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Co M, Ng J and Kwong A: De-novo metastatic
breast cancers with or without primary tumor resection-A 10-year
study. Cancer Treat Res Commun. 19:1001182019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Kwong A and Co M: Long term survival study
of de-novo metastatic breast cancers with or without primary tumour
resection. Cancer Treat Res Commun. 20:1001482019. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Rao R, Feng L, Kuerer HM, Singletary SE,
Bedrosian I, Hunt KK, Ross MI, Hortobagyi GN, Feig BW, Ames FC and
Babiera GV: Timing of surgical intervention for the intact primary
in stage IV breast cancer patients. Ann Surg Oncol. 15:1696–1702.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Cady B, Nathan NR, Michaelson JS, Golshan
M and Smith BL: Matched pair analyses of stage IV breast cancer
with or without resection of primary breast site. Ann Surg Oncol.
15:3384–3395. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Soran A, Özbaş S, Doğan L, Sezgin E, Özmen
V, Beriwal S and Brufsky A: Loco-regional treatment for intact
primary tumor in patient with de novo metastatic breast cancer;
comments and concerns of ECOG-ACRIN 2108 trial. Eur J Breast
Health. 16:158–159. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Poggio F, Lambertini M and de Azambuja E:
Surgery of the primary tumour in patients presenting with de novo
metastatic breast cancer: to do or not to do? ESMO Open.
3:e0003242018. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Teshome M: Role of operative management in
stage IV breast cancer. Surg Clin North Am. 98:859–868. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Altundag K: Questions about the primary
tumor resection for de-novo metastatic breast cancers. Cancer Treat
Res Commun. 20:1001312019. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Altundag K: Predictive role of
loco-regional radiotherapy among metastatic breast cancer patients
who had undergone primary tumor surgery. Breast Cancer Res Treat.
167:3032018. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Gultekin M, Yazici O, Eren G, Yuce D,
Aksoy S, Ozisik Y, Guler N, Yazici G, Hurmuz P, Yildiz F, et al:
Impact of locoregional treatment on survival in patients presented
with metastatic breast carcinoma. Breast. 23:775–783. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Kim YJ, Jung SY and Kim K: Survival
benefit of radiotherapy after surgery in de novo stage IV breast
cancer: A population-based propensity-score matched analysis. Sci
Rep. 9:85272019. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Tan Y, Li X, Chen H, Hu Y, Jiang M, Fu J,
Yuan Y and Ding K: Hormone receptor status may impact the survival
benefit of surgery in stage IV breast cancer: A population-based
study. Oncotarget. 7:70991–71000. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Wang K, Shi Y, Li ZY, Xiao YL, Li J, Zhang
X and Li HY: Metastatic pattern discriminates survival benefit of
primary surgery for de novo stage IV breast cancer: A real-world
observational study. Eur J Surg Oncol. 45:1364–1372. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Samiee S, Berardi P, Bouganim N,
Vandermeer L, Arnaout A, Dent S, Mirsky D, Chasen M, Caudrelier JM
and Clemons M: Excision of the primary tumour in patients with
metastatic breast cancer: A clinical dilemma. Curr Oncol.
19:e270–e279. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Rashaan ZM, Bastiaannet E, Portielje JE,
van de Water W, van der Velde S, Ernst MF, van de Velde CJ and
Liefers GJ: Surgery in metastatic breast cancer: Patients with a
favorable profile seem to have the most benefit from surgery. Eur J
Surg Oncol. 38:52–56. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Retsky M, Bonadonna G, Demicheli R,
Folkman J, Hrushesky W and Valagussa P: Hypothesis: Induced
angiogenesis after surgery in premenopausal node-positive breast
cancer patients is a major underlying reason why adjuvant
chemotherapy works particularly well for those patients. Breast
Cancer Res. 6:R372–E374. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
73
|
Hofer SO, Molema G, Hermens RA, Wanebo HJ,
Reichner JS and Hoekstra HJ: The effect of surgical wounding on
tumour development. Eur J Surg Oncol. 25:231–243. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
O'Reilly MS, Holmgren L, Shing Y, Chen C,
Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH and Folkman J:
Angiostatin: A novel angiogenesis inhibitor that mediates the
suppression of metastases by a Lewis lung carcinoma. Cell.
79:315–328. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Gunduz N, Fisher B and Saffer EA: Effect
of surgical removal on the growth and kinetics of residual tumor.
Cancer Res. 39:3861–3865. 1979.PubMed/NCBI
|
|
76
|
Rashid OM and Takabe K: Does removal of
the primary tumor in metastatic breast cancer improve survival? J
Womens Health (Larchmt). 23:184–188. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Cacho-Díaz B, García-Botello DR,
Wegman-Ostrosky T, Reyes-Soto G, Ortiz-Sánchez E and
Herrera-Montalvo LA: Tumor microenvironment differences between
primary tumor and brain metastases. J Transl Med. 18:12020.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Khodari W, Sedrati A, Naisse I, Bosc R and
Belkacemi Y; AROME (Association of Radiotherapy and Oncology of the
Mediterranean arEa; www.aromecancer.org), : Impact of loco-regional
treatment on metastatic breast cancer outcome: A review. Crit Rev
Oncol Hematol. 87:69–79. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Karnoub AE, Dash AB, Vo AP, Sullivan A,
Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R and Weinberg
RA: Mesenchymal stem cells within tumour stroma promote breast
cancer metastasis. Nature. 449:557–563. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Trovato R, Canè S, Petrova V, Sartoris S,
Ugel S and De Sanctis F: The engagement between MDSCs and
metastases: Partners in crime. Front Oncol. 10:1652020. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Moserle L, Amadori A and Indraccolo S: The
angiogenic switch: Implications in the regulation of tumor
dormancy. Curr Mol Med. 9:935–941. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Kazerounian S and Lawler J: Integration of
pro- and anti-angiogenic signals by endothelial cells. J Cell
Commun Signal. 12:171–179. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Kozłowski J, Kozłowska A and Kocki J:
Breast cancer metastasis-insight into selected molecular mechanisms
of the phenomenon. Postepy Hig Med Dosw (Online). 69:447–451. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Nguyen DH and Truong PT: A debate on
locoregional treatment of the primary tumor in patients presenting
with stage IV breast cancer. Expert Rev Anticancer Ther.
11:1913–1922. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Pantel K and Speicher MR: The biology of
circulating tumor cells. Oncogene. 35:1216–1224. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Wang WC and Zhang XF, Peng J, Li XF, Wang
AL, Bie YQ, Shi LH, Lin MB and Zhang XF: Survival mechanisms and
influence factors of circulating tumor cells. Biomed Res Int.
2018:63047012018. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Becker A, Thakur BK, Weiss JM, Kim HS,
Peinado H and Lyden D: Extracellular vesicles in cancer:
Cell-to-cell mediators of metastasis. Cancer Cell. 30:836–848.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Dos Anjos Pultz B, Andrés Cordero da Luz
F, Socorro Faria S, Peixoto Ferreira de Souza L, Cristina Brígido
Tavares P, Alonso Goulart V, Fontes W, Ricardo Goulart L and José
Barbosa Silva M: The multifaceted role of extracellular vesicles in
metastasis: Priming the soil for seeding. Int J Cancer.
140:2397–2407. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Wortzel I, Dror S, Kenific CM and Lyden D:
Exosome-mediated metastasis: Communication from a distance. Dev
Cell. 49:347–360. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Wong CC, Gilkes DM, Zhang H, Chen J, Wei
H, Chaturvedi P, Fraley SI, Wong CM, Khoo US, Ng IO, et al:
Hypoxia-inducible factor 1 is a master regulator of breast cancer
metastatic niche formation. Proc Natl Acad Sci USA.
108:16369–16374. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Noguchi M, Nakano Y, Noguchi M, Ohno Y and
Kosaka T: Local therapy and survival in breast cancer with distant
metastases. J Surg Oncol. 105:104–110. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Yousefi M, Nosrati R, Salmaninejad A,
Dehghani S, Shahryari A and Saberi A: Organ-specific metastasis of
breast cancer: Molecular and cellular mechanisms underlying lung
metastasis. Cell Oncol (Dordr). 41:123–140. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Sun S and Qiu XS: Cancer stem cells and
tumor metastasis. J Cancer Res Ther. 9 (Suppl):S150–S152. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Marcuzzi E, Angioni R, Molon B and Calì B:
chemokines and chemokine receptors: Orchestrating tumor
metastasization. Int J Mol Sci. 20:962018. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
O'Hayre M, Salanga CL, Handel TM and Allen
SJ: Chemokines and cancer: Migration, intracellular signalling and
intercellular communication in the microenvironment. Biochem J.
409:635–649. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Ma R, Feng Y, Lin S, Chen J, Lin H, Liang
X, Zheng H and Cai X: Mechanisms involved in breast cancer liver
metastasis. J Transl Med. 13:642015. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Seguin L, Desgrosellier JS, Weis SM and
Cheresh DA: Integrins and cancer: Regulators of cancer stemness,
metastasis, and drug resistance. Trends Cell Biol. 25:234–240.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Naxerova K and Jain RK: Using tumour
phylogenetics to identify the roots of metastasis in humans. Nat
Rev Clin Oncol. 12:258–272. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Norton L and Massagué J: Is cancer a
disease of self-seeding? Nat Med. 12:875–878. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Danna EA, Sinha P, Gilbert M, Clements VK,
Pulaski BA and Ostrand-Rosenberg S: Surgical removal of primary
tumor reverses tumor-induced immunosuppression despite the presence
of metastatic disease. Cancer Res. 64:2205–2211. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Criscitiello C, Giuliano M, Curigliano G,
De Laurentiis M, Arpino G, Carlomagno N, De Placido S, Golshan M
and Santangelo M: Surgery of the primary tumor in de novo
metastatic breast cancer: To do or not to do? Eur J Surg Oncol.
41:1288–1292. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Jiang ZF, Cristofanilli M, Shao ZM, Tong
ZS, Song EW, Wang XJ, Liao N, Hu XC, Liu Y, Wang Y, et al:
Circulating tumor cells predict progression-free and overall
survival in Chinese patients with metastatic breast cancer,
HER2-positive or triple-negative (CBCSG004): A multicenter,
double-blind, prospective trial. Ann Oncol. 24:2766–2772. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Cristofanilli M, Budd GT, Ellis MJ,
Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ,
Terstappen LWMM and Hayes DF: Circulating tumor cells, disease
progression, and survival in metastatic breast cancer. N Engl J
Med. 351:781–791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Hazard HW, Gorla SR, Scholtens D, Kiel K,
Gradishar WJ and Khan SA: Surgical resection of the primary tumor,
chest wall control, and survival in women with metastatic breast
cancer. Cancer. 113:2011–2019. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Dauplat J, Le Bouëdec G, Pomel C and
Scherer C: Cytoreductive surgery for advanced stages of ovarian
cancer. Semin Surg Oncol. 19:42–48. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Dooley WC: A surgical indication in
incurable breast cancer. Ann Surg Oncol. 13:759–760. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Ruiterkamp J, Ernst MF, van de Poll-Franse
LV, Bosscha K, Tjan-Heijnen VC and Voogd AC: Surgical resection of
the primary tumour is associated with improved survival in patients
with distant metastatic breast cancer at diagnosis. Eur J Surg
Oncol. 35:1146–1151. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Leung AM, Vu HN, Nguyen KA, Thacker LR and
Bear HD: Effects of surgical excision on survival of patients with
stage IV breast cancer. J Surg Res. 161:83–88. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Pathy NB, Verkooijen HM, Taib NA, Hartman
M and Yip CH: Impact of breast surgery on survival in women
presenting with metastatic breast cancer. Br J Surg. 98:1566–1572.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Bertaut A, Mounier M, Desmoulins I, Guiu
S, Beltjens F, Darut-Jouve A, Ponnelle T, Arnould L and Arveux P:
Stage IV breast cancer: A population-based study about prognostic
factors according to HER2 and HR status. Eur J Cancer Care (Engl).
24:920–928. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Lopez-Tarruella S, Escudero MJ, Pollan M,
Martín M, Jara C, Bermejo B, Guerrero-Zotano A, García-Saenz J,
Santaballa A, Alba E, et al: Survival impact of primary tumor
resection in de novo metastatic breast cancer patients (GEICAM/El
Alamo Registry). Sci Rep. 9:200812019. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Pons-Tostivint E, Kirova Y, Lusque A,
Campone M, Geffrelot J, Rivera S, Mailliez A, Pasquier D, Madranges
N, Firmin N, et al: Radiation therapy to the primary tumor for de
novo metastatic breast cancer and overall survival in a
retrospective multicenter cohort analysis. Radiother Oncol.
145:109–116. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Rosche M, Regierer AC,
Schwarzlose-Schwarck S, Weigel A, Bangemann N, Schefe JH, Scholz
CW, Possinger K and Eucker J: Primary tumor excision in stage IV
breast cancer at diagnosis without influence on survival: A
retrospective analysis and review of the literature. Onkologie.
34:607–612. 2011. View Article : Google Scholar : PubMed/NCBI
|
